Top Stock Gainers
Explore the biggest stock gainers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock gainers every day with market data, news, and analysis from our Foolish experts.
Related Articles
bioAffinity Misses Q2 Revenue Target
Motley Fool Markets Team
|
Aug 14, 2025
Everyone's Talking About These 2 Biotech IPO Stocks, But Are They Buys?
Alex Carchidi
|
Feb 25, 2024
The market's excited for these stocks, but there's no rush to buy them.
I-MAB (IMAB) Q2 2021 Earnings Call Transcript
Motley Fool Transcribers
|
Aug 31, 2021
IMAB earnings call for the period ending June 30, 2021.
IMab ADR (IMAB) Q4 2020 Earnings Call Transcript
Motley Fool Transcribers
|
Mar 29, 2021
IMAB earnings call for the period ending December 31, 2020.
Minerva Neurosciences (NERV) Q4 2020 Earnings Call Transcript
Motley Fool Transcribing
|
Mar 8, 2021
NERV earnings call for the period ending December 31, 2020.
Minerva Neurosciences (NERV) Q3 2020 Earnings Call Transcript
Motley Fool Transcribing
|
Nov 3, 2020
NERV earnings call for the period ending September 30, 2020.
AbbVie Partners With I-Mab for Cancer Drug
Jim Crumly
|
Sep 4, 2020
The deal could be the largest-ever out-licensing agreement by a Chinese biotech.
Minerva Neurosciences (NERV) Q2 2020 Earnings Call Transcript
Motley Fool Transcribing
|
Aug 3, 2020
NERV earnings call for the period ending June 30, 2020.
Why Minerva Neurosciences Is Heading Higher Today
George Budwell
|
Jun 1, 2020
The biotech's shares are mounting a modest comeback after their ugly decline on Friday.
View More Articles